Institutional investors purchased a net $4.0 million shares of DEPO during the quarter ended June 2015 and now own 112.82% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SENVEST MANAGEMENT LLC Bought 514.4 Thousand shares of Depomed Inc